GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
322.41B
PBQQX
Price
$25.15
Change
+$0.10 (+0.40%)
Updated
Aug 6 closing price
Net Assets
1.05B
Interact to see
Advertisement

GFACX vs PBQQX

Header iconGFACX vs PBQQX Comparison
Open Charts GFACX vs PBQQXBanner chart's image
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets322.41B
PGIM Jennison Blend R6
Price$25.15
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets1.05B
GFACX vs PBQQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. PBQQX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and PBQQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 322B vs. PBQQX (1.05B). PBQQX pays higher dividends than GFACX: PBQQX (0.76) vs GFACX (0.00). GFACX was incepted earlier than PBQQX: GFACX (24 years) vs PBQQX (8 years). PBQQX (2.99) is less costly to investors than GFACX (1.36). PBQQX is a more actively managed with annual turnover of: 47.00 vs. GFACX (25.00). PBQQX has a lower initial minimum investment than GFACX: PBQQX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 18.41 vs. PBQQX (4.04). GFACX return over 5 years is better than : 33.13 vs. PBQQX (16.70).
GFACXPBQQXGFACX / PBQQX
Total Expense Ratio1.360.64213%
Annual Report Gross Expense Ratio1.362.9945%
Fund Existence24 years8 years-
Gain YTD12.1712.959411%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets322B1.05B30,608%
Annual Yield % from dividends0.000.76-
Returns for 1 year18.414.04456%
Returns for 3 years39.6326.77148%
Returns for 5 years33.1316.70198%
Returns for 10 years67.85N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial